Research Spotlight: Maternal Insulin Sensitivity/Resistance During Pregnancy
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
Read the latest news from Massachusetts General Hospital.
Our publication keeps health care professionals up to date on the latest research and clinical advances from Mass General.
News and notes from the largest hospital-based research program in the United States
A podcast devoted to uncovering the stories of Mass General's relentless pursuit to break boundaries and provide exceptional care
The findings set the stage for novel approaches to modulate insulin resistance in pregnancy and prevent or treat gestational diabetes mellitus (GDM).
The study was designed to compare four major medications approved by the FDA to treat diabetes in combination with metformin, the usual first-line drug.
Researchers have identified numerous genetic clusters that may help explain why people with type 2 diabetes have different clinical presentations.
The findings can be used to improve prediction and develop preventive strategies for type 2 diabetes and to identify new drug targets to treat the disease.
In a study of individuals at risk for developing type 2 diabetes, researchers identified genetic variants linked with participants’ responses to two different blood sugar–lowering drugs.
New research led by investigators at Massachusetts General Hospital (MGH), a founding member of Mass General Brigham (MGB), indicates that socioeconomic and genetic factors likely interact in an additive way to affect people’s risks of developing obesity and type 2 diabetes.
The Patient Gateway provides secure online access to your health information whenever you need it. Check upcoming appointments, communicate with your doctor’s office, review medications and pay medical bills—all seamlessly online 24/7.